Lakefront Biotherapeutics | GLPG - Należności Handlowe





Należności Handlowe Zmiana Data
argenx SE USD 2.01B 352.94M 2026-06
AstraZeneca USD 18.86B 972M 2026-06
Biogen USD 1.79B 76.6M 2026-03
Genmab DKK 1.22B 192M 2026-06
Gilead Sciences USD 5.06B 314M 2026-06
GlaxoSmithKline GBP 8.07B 137M 2026-06
GRIFOLS EUR 1.19B 231M 2026-06
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Incyte USD 1.13B 73.7M 2026-06
Merck EUR 4.95B 139M 2026-06
Neurocrine Biosciences USD 887M 118.9M 2026-06
Novartis USD 9.85B 252M 2026-06
Roche Holding CHF 13.34B 1.44B 2026-06
Sanofi EUR 492M 10M 2026-06
UCB EUR 1.97B 54M 2025-12
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06